Stereotactic body radiation therapy with higher biologically effective dose is associated with improved survival in stage II non-small cell lung cancer.

Yan, Sherry X

Stereotactic body radiation therapy with higher biologically effective dose is associated with improved survival in stage II non-small cell lung cancer. [electronic resource] - Lung cancer (Amsterdam, Netherlands) 05 2019 - 147-153 p. digital

Publication Type: Journal Article

1872-8332

10.1016/j.lungcan.2019.03.031 doi


Aged
Aged, 80 and over
Carcinoma, Non-Small-Cell Lung--mortality
Female
Follow-Up Studies
Humans
Lung Neoplasms--mortality
Lymphatic Metastasis
Male
Middle Aged
Neoplasm Staging
Radiosurgery--methods
Radiotherapy Dosage
Survival Analysis
Treatment Outcome